SMAD7 and neoplasm: Park et al., evaluated Smad7 in the different phases of hepatocellular carcinoma (HCC) development and documented Smad7-expressing tumor cells in 25 out of 41 (61%) advanced tumors whereas no Smad7-positive cells were detected in dysplastic nodules and early HCCs [73].